FeesSafety
Pluang+

EXL named Leader and Star Performer in Everest Group CXM PEAK Matrix 2026 for AI-driven customer experience solutions

Market News
03 Nov 2026, 15:33 WIB
GlobeNewsWire
View Source
Bullish
EXL named Leader and Star Performer in Everest Group CXM PEAK Matrix 2026 for AI-driven customer experience solutions

EXL, a global data and AI company, has been recognized as a Leader and Star Performer in the Everest Group Customer Experience Management (CXM) PEAK Matrix Assessment – Americas 2026. This recognition highlights EXL's strong domain expertise, flexible AI-enabled CXM solutions, and proven ability to transform customer experiences across sectors like healthcare and retail. The company advanced from a Major Contributor in 2025 to a Leader in 2026, reflecting its growing impact and innovation in AI-driven customer service transformation. EXL's investments in AI, analytics, and automation position it well to help clients improve customer satisfaction and operational performance.

EXL's recognition as a Leader and Star Performer in the Everest Group Customer Experience Management PEAK Matrix Assessment 2026 provides context for technology sector activity on Pluang. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 03, 2026 19:43 WIB: out of 150 priced US tech stocks, 73 rose and 76 fell. Notable movers include GRAB at USD 3.16 with a 10.49% increase, DOCN at USD 83.40 down 7.12%, and GPRO at USD 1.01 up 6.25%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App